Retracted: Difference between Acyclovir and Ganciclovir in the Treatment of Children with Epstein–Barr Virus-Associated Infectious Mononucleosis

Detalles Bibliográficos
Autor principal: and Alternative Medicine, Evidence-Based Complementary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307344/
https://www.ncbi.nlm.nih.gov/pubmed/37387896
http://dx.doi.org/10.1155/2023/9783107
_version_ 1785066025265397760
author and Alternative Medicine, Evidence-Based Complementary
author_facet and Alternative Medicine, Evidence-Based Complementary
author_sort and Alternative Medicine, Evidence-Based Complementary
collection PubMed
description
format Online
Article
Text
id pubmed-10307344
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-103073442023-06-29 Retracted: Difference between Acyclovir and Ganciclovir in the Treatment of Children with Epstein–Barr Virus-Associated Infectious Mononucleosis and Alternative Medicine, Evidence-Based Complementary Evid Based Complement Alternat Med Retraction Hindawi 2023-06-21 /pmc/articles/PMC10307344/ /pubmed/37387896 http://dx.doi.org/10.1155/2023/9783107 Text en Copyright © 2023 Evidence-Based Complementary and Alternative Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
and Alternative Medicine, Evidence-Based Complementary
Retracted: Difference between Acyclovir and Ganciclovir in the Treatment of Children with Epstein–Barr Virus-Associated Infectious Mononucleosis
title Retracted: Difference between Acyclovir and Ganciclovir in the Treatment of Children with Epstein–Barr Virus-Associated Infectious Mononucleosis
title_full Retracted: Difference between Acyclovir and Ganciclovir in the Treatment of Children with Epstein–Barr Virus-Associated Infectious Mononucleosis
title_fullStr Retracted: Difference between Acyclovir and Ganciclovir in the Treatment of Children with Epstein–Barr Virus-Associated Infectious Mononucleosis
title_full_unstemmed Retracted: Difference between Acyclovir and Ganciclovir in the Treatment of Children with Epstein–Barr Virus-Associated Infectious Mononucleosis
title_short Retracted: Difference between Acyclovir and Ganciclovir in the Treatment of Children with Epstein–Barr Virus-Associated Infectious Mononucleosis
title_sort retracted: difference between acyclovir and ganciclovir in the treatment of children with epstein–barr virus-associated infectious mononucleosis
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307344/
https://www.ncbi.nlm.nih.gov/pubmed/37387896
http://dx.doi.org/10.1155/2023/9783107
work_keys_str_mv AT andalternativemedicineevidencebasedcomplementary retracteddifferencebetweenacyclovirandganciclovirinthetreatmentofchildrenwithepsteinbarrvirusassociatedinfectiousmononucleosis

Ejemplares similares